PreveCeutical Medical Inc.

OTC: PRVCF · Healthcare · Biotechnology

Canadian filerHQ Vancouver, BCReports USD

#1143 of 1,394 Healthcare companies by revenue

EA Score

——

FH 22DQ —GM —SS 37

v0.1 · 35/100 weight · pillars only

↑ disclosure history, market scale · ↓ balance-sheet leverage, Piotroski F

Methodology →

Revenue TTM

Rev growth YoY (TTM)

needs 8 qtrs

Net income (FY)

-$1.1M

Employees

Market cap

$6.5M

Financials — latest annual

SEC EDGAR · USD-normalized

ConceptUSDNativeFY

Revenue$00 CAD2025

Net income-$1.1M-1.6M CAD2025

Operating income-$2.4M-3.4M CAD2025

Total assets$1.1M1.4M CAD2025

Liabilities$5.6M7.7M CAD2025

Equity-$4.6M-6.2M CAD2025

Revenue trend

FY2018 – FY2025 · USD

$11.9k

FY18

$2.3k

FY19

FY20

FY21

FY22

FY23

FY24

FY25

Revenue by segment

No segmentation disclosed for this filer. n/a

The read

PreveCeutical Medical Inc. booked $0 in FY2025 revenue — among the slowest-growing Healthcare companies we track, at a -Infinity% net margin.

Peers · Healthcare

Sweet Earth Holdings Corporation22D Citius Pharmaceuticals, Inc.43D Glow Lifetech Corp.——AI Maverick Intel, Inc.——

Key facts

CEOStephen Van Deventer

SectorHealthcare

IndustryBiotechnology

HeadquartersVancouver, BC

ExchangeOTC: PRVCF

Employees7

IPO date2017-08-21

Latest filings

No filings loaded — no CIK (non-SEC filer).

Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.